TREATMENT FOR NON-ALCOHOLIC FATTY LIVER DISEASEThe invention provides novel methods of treating or preventing nonalcoholic fatty liver disease (NAFLD) including non-alcoholic steatohepatitis (NASH) in a mammal including a human.LI, CHIANG, J.
cirrhosis,end-stage liver disease (ESRD), and hepatocellular carcinoma (HCC) is emerging as a global epidemic.Obesity, diabetes, and metabolic syndrome are some of the leading risk factors for NAFLD. The mostprevalent treatment to stop the progression is aimed at dietary modification...
Chinese herbal medicine has developed new therapies for nonalcoholic fatty liver disease (NAFLD) based on its unique theory system and substantial herb remedies. In this review, 21 traditional Chinese herbs were introduced for their potential benefit in the treatment of NAFLD. Majority of them are ...
Hence, long-chain omega-3 fatty acids may be a promising option for the treatment of NAFLD, even in children and adolescents. However, other aspects and measures should be considered. 展开 关键词: cardiovascular risk children clinical outcome efficacy nonalcoholic fatty liver disease omega-3 ...
A recently developed amino acid compound successfully treats nonalcoholic fatty liver disease in non-human primates—bringing scientists one step closer to the first human treatment for the condition that is rapidly increasing around the world, a study suggests. ...
Key words: Alcoholic liver disease; non-alcoholic fatty WJG|www.wjgnet.com 6549 September 28, 2017|Volume 23|Issue 36| Singh S et al . Treatment options for ALD and NAFLD liver disease; Treatment options; Glucocorticoids; Liver transplantation © The Author(s) 2017. ...
Non-alcoholic fatty liver disease(NAFLD) has been recognized as a major health burden.It is the most important cause of chronic liver disease and a major independent cardiovascular risk factor.Lacking a definite treatment for NAFLD,a specific diet and an increase in physical activity represent the...
It is part of the disease spectrum of non-alcoholic fatty liver disease, which is now thought to be the most common cause of chronic liver disease in the US and other Western countries. Initially this condition was considered innocuous but it is now recognised as having the potential to ...
Bariatric surgery significantly reduces the risk of major adverse liver and cardiovascular events in recipients, compared with nonsurgical counterparts, among those with nonalcoholic fatty liver disease.
Non-alcoholic fatty liver disease is a clinical pathological syndrome characterized by diffuse hepatocellular macrovesicular steatosis caused by other liver-damaging factors except for alcohol. At present, there are no specific drugs for non-alcoholic fatty liver disease in the Eastern world or the ...